Escherichia Coli Enteritis in Ireland
Rates of disease due to Verotoxin-producing Escherichia coli (VTEC) in Ireland have increased dramatically since 2010, and are currently eight-fold those reported in the United States.  Significantly, corresponding rates of hemolytic-uremic syndrome and E. coli O157 infection in Ireland have changed little during this period. [1-3] References: Berger S. Escherichia coli Diarrhea: Global Status, 2018. 232 pages , 157 graphs , 4,551 references. Gideon e-books,  https://www.gideononline.com/ebooks/disease/escherichia-coli-diarrhea-global-status/ Berger S. Infectious Diseases of Ireland and Northern Ireland, 2018.  4...
Source: GIDEON blog - July 5, 2018 Category: Databases & Libraries Authors: Dr. Stephen Berger Tags: Ebooks Epidemiology Graphs ProMED Source Type: blogs

Precision Medicine and the Reinvention of Human Disease (Book Index)
In January, 2018, Academic Press published my bookPrecision Medicine and the Reinvention of Human Disease. This book has an excellent " look inside " at itsGoogle book site, which includes the Table of Contents. In addition, I thought it might be helpful to see the topics listed in the Book ' s index. Note that page numbers followed by f indicate figures, t indicate tables, and ge indicate glossary terms.AAbandonware, 270, 310geAb initio, 34, 48ge, 108geABL (abelson leukemia) gene, 28, 58ge, 95 –97Absidia corymbifera, 218Acanthameoba, 213Acanthosis nigricans, 144geAchondroplasia, 74, 143ge, 354geAcne, 54ge, 198, 220geAcq...
Source: Specified Life - January 23, 2018 Category: Information Technology Tags: index jules berman jules j berman precision medicine Source Type: blogs

Reference Labs Provide Patient Test Information to Rare Drug Manufacturer
A recent outstanding article inBloomberg by Ben Elgin and Caroline Chen detailed how Alexion Pharmaceutical developed a drug calledSoliris to treatparoxysmal nocturnal hemoglobinuria andatypical hemolytic uremic syndrome (aHUS) (see:When the Patient Is a Gold Mine: The Trouble With Rare-Disease Drugs). The cost for this drug is astronomical but there are not many patients requiring treatment. Company reps therefore closely keep of track patients with the diseases. There is also a history of reps aggressively marketing the drug. Unfortunately,"partner labs" seem to h...
Source: Lab Soft News - June 2, 2017 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Clinical Lab Industry News Clinical Lab Testing Cost of Healthcare Lab Industry Trends Lab Information Lab Processes and Procedures Medical Ethics Pharmaceutical Industry Reference Laboratories Source Type: blogs

Reference Labs Provide Patient Test Information to Pharmaceutical Company
A recent outstanding article inBloomberg by Ben Elgin and Caroline Chen detailed how Alexion Pharmaceutical developed a drug calledSoliris to treatparoxysmal nocturnal hemoglobinuria andatypical hemolytic uremic syndrome (aHUS) (see:When the Patient Is a Gold Mine: The Trouble With Rare-Disease Drugs). The cost for this drug is astronomical but there are not many patients requiring treatment. Company reps therefore closely keep of track patients with the diseases. There is also a history of reps aggressively marketing the drug. Unfortunately,"partner labs" seem to h...
Source: Lab Soft News - June 2, 2017 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Clinical Lab Industry News Clinical Lab Testing Cost of Healthcare Lab Industry Trends Lab Information Lab Processes and Procedures Medical Ethics Pharmaceutical Industry Reference Laboratories Source Type: blogs

Shigatoxin associated hemolytic uremic syndrome (D+ HUS)
(Source: Notes from Dr. RW)
Source: Notes from Dr. RW - May 12, 2013 Category: Internists and Doctors of Medicine Tags: gastroenterology infectious disease hematology nephrology Source Type: blogs

Epidemiology Pathogenesis and Genetics of Diarrhoeagenic Escherichia coli Infections
Epidemiology, Pathogenesis and Genetics of Diarrhoeagenic Escherichia coli Infectionsfrom T. Ramamurthy and M. John Albert writing in Foodborne and Waterborne Bacterial Pathogens: Epidemiology, Evolution and Molecular Biology:There are five categories of diarrhoeagenic Escherichia coli (DEC) namely enterotoxigenic, enteropathogenic, enterohaemorrhagic, enteroinvasive and enteroaggregative. They have evolved from nonpathogenic commensal strains by acquisition of specific virulence genes through mobile genetic elements. Their pathogenesis differs and they produce distinct clinical syndromes and pathological lesions and have ...
Source: Microbiology Blog: The weblog for microbiologists. - January 4, 2013 Category: Microbiology Source Type: blogs